Research programme: human protein therapeutics - Klotho therapeutics

Drug Profile

Research programme: human protein therapeutics - Klotho therapeutics

Latest Information Update: 11 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Klotho Therapeutics
  • Class Enzymes; Proteins
  • Mechanism of Action TRPC6 cation channel modulators; TRPV cation channel modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Research Cancer; Cognition disorders; Diabetes mellitus; Kidney disorders

Most Recent Events

  • 02 Nov 2017 Klotho therapeutics announces intention to submit IND application to the US FDA
  • 02 Nov 2017 Klotho therapeutics plans a first-in-human trial for Kidney disorders
  • 02 Nov 2017 Early research in Cancer in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top